CXCL11 and breast carcinoma: This is in agreement with clinical studies in human breast cancer identifying CXCL9, rather than CXCL10 or CXCL11, as a potential biomarker for diagnosis of breast cancer and therapy response, suggestive of its protective role in breast cancer biology [14,15,37].